119 related articles for article (PubMed ID: 33464748)
21. Analysis of KIAA1549-BRAF fusion status in a case of rosette-forming glioneuronal tumor of the fourth ventricle (RGNT).
Gessi M; Waha A; Setty P; Waha A; Pietsch T
Neuropathology; 2011 Dec; 31(6):654-7. PubMed ID: 21518014
[TBL] [Abstract][Full Text] [Related]
22. Gastrointestinal stromal tumors with BRAF gene fusions. A report of two cases showing low or absent KIT expression resulting in diagnostic pitfalls.
Torrence D; Xie Z; Zhang L; Chi P; Antonescu CR
Genes Chromosomes Cancer; 2021 Dec; 60(12):789-795. PubMed ID: 34398495
[TBL] [Abstract][Full Text] [Related]
23. S100 and CD34 Expressing Mesenchymal Neoplasm With Rare PLEKHH2::ALK Fusion and Response to ALK Inhibition.
Coppock JD; Schneider MA; Surrey LF; Karakousis GC; Maki RG; Cooper K
Am J Surg Pathol; 2022 Sep; 46(9):1309-1313. PubMed ID: 35288525
[TBL] [Abstract][Full Text] [Related]
24. Analysis of IDH1-R132 mutation, BRAF V600 mutation and KIAA1549-BRAF fusion transcript status in central nervous system tumors supports pediatric tumor classification.
Gierke M; Sperveslage J; Schwab D; Beschorner R; Ebinger M; Schuhmann MU; Schittenhelm J
J Cancer Res Clin Oncol; 2016 Jan; 142(1):89-100. PubMed ID: 26115961
[TBL] [Abstract][Full Text] [Related]
25. RAF1-rearranged spindle cell tumour: report of two additional cases with identification of a novel FMR1-RAF1 fusion.
Zhang T; Wang Q; Yi X; Zhu P
Virchows Arch; 2021 Dec; 479(6):1245-1253. PubMed ID: 34459981
[TBL] [Abstract][Full Text] [Related]
26. KIAA1549:BRAF fusion gene in pediatric brain tumors of various histogenesis.
Antonelli M; Badiali M; Moi L; Buttarelli FR; Baldi C; Massimino M; Sanson M; Giangaspero F
Pediatr Blood Cancer; 2015 Apr; 62(4):724-7. PubMed ID: 25382612
[TBL] [Abstract][Full Text] [Related]
27. Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternatives to KIAA1549:BRAF fusion in activating the MAPK pathway in pilocytic astrocytoma.
Jones DT; Kocialkowski S; Liu L; Pearson DM; Ichimura K; Collins VP
Oncogene; 2009 May; 28(20):2119-23. PubMed ID: 19363522
[TBL] [Abstract][Full Text] [Related]
28. Soft tissue tumors characterized by a wide spectrum of kinase fusions share a lipofibromatosis-like neural tumor pattern.
Kao YC; Suurmeijer AJH; Argani P; Dickson BC; Zhang L; Sung YS; Agaram NP; Fletcher CDM; Antonescu CR
Genes Chromosomes Cancer; 2020 Oct; 59(10):575-583. PubMed ID: 32506523
[TBL] [Abstract][Full Text] [Related]
29. Novel BRAF gene fusions and activating point mutations in spindle cell sarcomas with histologic overlap with infantile fibrosarcoma.
Penning AJ; Al-Ibraheemi A; Michal M; Larsen BT; Cho SJ; Lockwood CM; Paulson VA; Liu YJ; Plank L; Fritchie K; Beadling C; Neff TL; Corless CL; Rudzinski ER; Davis JL
Mod Pathol; 2021 Aug; 34(8):1530-1540. PubMed ID: 33850302
[TBL] [Abstract][Full Text] [Related]
30. Integrating Next-Generation Sequencing with Morphology Improves Prognostic and Biologic Classification of Spitz Neoplasms.
Quan VL; Zhang B; Zhang Y; Mohan LS; Shi K; Wagner A; Kruse L; Taxter T; Beaubier N; White K; Zou L; Gerami P
J Invest Dermatol; 2020 Aug; 140(8):1599-1608. PubMed ID: 32004563
[TBL] [Abstract][Full Text] [Related]
31. Superficial ALK-rearranged myxoid spindle cell neoplasm: a cutaneous soft tissue tumor with distinctive morphology and immunophenotypic profile.
Dermawan JK; Azzato EM; Goldblum JR; Rubin BP; Billings SD; Ko JS
Mod Pathol; 2021 Sep; 34(9):1710-1718. PubMed ID: 34088997
[TBL] [Abstract][Full Text] [Related]
32. BRAF fusions define a distinct molecular subset of melanomas with potential sensitivity to MEK inhibition.
Hutchinson KE; Lipson D; Stephens PJ; Otto G; Lehmann BD; Lyle PL; Vnencak-Jones CL; Ross JS; Pietenpol JA; Sosman JA; Puzanov I; Miller VA; Pao W
Clin Cancer Res; 2013 Dec; 19(24):6696-702. PubMed ID: 24345920
[TBL] [Abstract][Full Text] [Related]
33. Oncogenic FAM131B-BRAF fusion resulting from 7q34 deletion comprises an alternative mechanism of MAPK pathway activation in pilocytic astrocytoma.
Cin H; Meyer C; Herr R; Janzarik WG; Lambert S; Jones DT; Jacob K; Benner A; Witt H; Remke M; Bender S; Falkenstein F; Van Anh TN; Olbrich H; von Deimling A; Pekrun A; Kulozik AE; Gnekow A; Scheurlen W; Witt O; Omran H; Jabado N; Collins VP; Brummer T; Marschalek R; Lichter P; Korshunov A; Pfister SM
Acta Neuropathol; 2011 Jun; 121(6):763-74. PubMed ID: 21424530
[TBL] [Abstract][Full Text] [Related]
34. Chromosome band 7q34 deletions resulting in KIAA1549-BRAF and FAM131B-BRAF fusions in pediatric low-grade Gliomas.
Roth JJ; Santi M; Pollock AN; Harding BN; Rorke-Adams LB; Tooke LS; Biegel JA
Brain Pathol; 2015 Mar; 25(2):182-92. PubMed ID: 25040262
[TBL] [Abstract][Full Text] [Related]
35. BRAF V600E and decreased NIS and TPO expression are associated with aggressiveness of a subgroup of papillary thyroid microcarcinoma.
Bastos AU; Oler G; Nozima BH; Moysés RA; Cerutti JM
Eur J Endocrinol; 2015 Oct; 173(4):525-40. PubMed ID: 26338373
[TBL] [Abstract][Full Text] [Related]
36. Whole Chromosome 7 Gain Predicts Higher Risk of Recurrence in Pediatric Pilocytic Astrocytomas Independently From KIAA1549-BRAF Fusion Status.
Roth JJ; Fierst TM; Waanders AJ; Yimei L; Biegel JA; Santi M
J Neuropathol Exp Neurol; 2016 Apr; 75(4):306-15. PubMed ID: 26945035
[TBL] [Abstract][Full Text] [Related]
37. Multiplex Detection of Pediatric Low-Grade Glioma Signature Fusion Transcripts and Duplications Using the NanoString nCounter System.
Ryall S; Arnoldo A; Krishnatry R; Mistry M; Khor K; Sheth J; Ling C; Leung S; Zapotocky M; Guerreiro Stucklin A; Lassaletta A; Shago M; Tabori U; Hawkins CE
J Neuropathol Exp Neurol; 2017 Jul; 76(7):562-570. PubMed ID: 28863456
[TBL] [Abstract][Full Text] [Related]
38. Analysis of KIAA1549-BRAF fusion gene expression and IDH1/IDH2 mutations in low grade pediatric astrocytomas.
Cruz GR; Dias Oliveira I; Moraes L; Del Giudice Paniago M; de Seixas Alves MT; Capellano AM; Saba-Silva N; Cavalheiro S; Cerutti JM; Toledo SR
J Neurooncol; 2014 Apr; 117(2):235-42. PubMed ID: 24532263
[TBL] [Abstract][Full Text] [Related]
39. Dermal lipofibromatosis-like neural tumor.
Llamas-Velasco M; Itlinger-Monshi B; Flucke U; Mentzel T
J Cutan Pathol; 2022 Jun; 49(6):525-531. PubMed ID: 35195930
[TBL] [Abstract][Full Text] [Related]
40. Absence of KIAA1549-BRAF fusion in rosette-forming glioneuronal tumors of the fourth ventricle (RGNT).
Gessi M; Lambert SR; Lauriola L; Waha A; Collins VP; Pietsch T
J Neurooncol; 2012 Oct; 110(1):21-5. PubMed ID: 22814862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]